UCLA JCCC Clinical Research Unit

Los Angeles, California 90095

3 studies enrolling now · 9 studies all time

What they study most

Advanced Solid Tumor, Colorectal Cancer, Endometrial Cancer, Endometrioid Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Hepatocellular Carcinoma, NSCLC, Ovarian Cancer, Pancreas Cancer

Studies at this site

• First in Human Study of TORL-1-23 in Participants With Advanced Cancer — Recruiting now
• CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. — Recruiting now
• A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer — Recruiting now
• First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer — Running, not enrolling
• First in Human Study of TORL-3-600 in Participants With Advanced Cancer — Running, not enrolling
• First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer — Running, not enrolling
• First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors — Stopped early
• First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors — Status unconfirmed
• A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer — Stopped early